UK markets close in 5 minutes

Molecular Partners AG (MOLN)

NasdaqGS - NasdaqGS Delayed price. Currency in USD
Add to watchlist
6.000.00 (0.00%)
As of 09:51AM EDT. Market open.
Show:
Balance sheet
Cash flow
Annual

Income statement

Currency in CHF. All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
189,556
189,556
9,330
9,344
20,383
Operating expenses
Research development
50,749
50,749
55,718
56,075
43,498
Selling general and administrative
21,822
21,822
16,906
11,027
13,164
Total operating expenses
72,943
72,943
72,749
67,670
57,043
Operating income or loss
116,613
116,613
-63,419
-58,326
-36,660
Interest expense
605
605
548
271
27
Total other income/expenses net
717
717
92
-4,513
-1,110
Income before tax
117,853
117,853
-63,783
-62,775
-36,271
Income tax expense
0
0
2
-11
17
Income from continuing operations
117,853
117,853
-63,785
-62,764
-36,288
Net income
117,853
117,853
-63,785
-62,764
-36,288
Net income available to common shareholders
117,853
117,853
-63,785
-62,764
-36,288
Basic EPS
-
3.63
-2.06
-2.51
-1.69
Diluted EPS
-
3.54
-2.06
-2.51
-1.69
Basic average shares
-
32,470
31,005
25,001
21,413
Diluted average shares
-
33,266
31,005
25,001
21,413
EBITDA
-
120,846
-60,670
-59,617
-33,775